Loading clinical trials...
Loading clinical trials...
This study is designed to provide short term efficacy and safety data of TRI476 in children with inadequately-controlled partial seizures. Patients will be randomized into either drug treatment or pla...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT06960811 · Epilepsy With Partial Onset Seizures With or Without Secondary Generalization, Psychoses, and more
NCT01830868 · Partial Onset Seizures
NCT03288129 · Partial Onset Seizures, Secondarily Generalized Seizures, and more
NCT02072824 · Partial Onset Seizures
NCT00655486 · Partial Epilepsies, Partial Onset Seizures
Novartis Investigative Site
Nagoya, Aichi-ken
Novartis Investigative Site
Ohbu, Aichi-ken
Novartis Investigative Site
Matsuyama, Ehime
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions